| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 40.25B | 37.56B | 36.35B | 36.06B | 35.45B |
| Gross Profit | 11.01B | 18.43B | 18.23B | 18.15B | 17.73B |
| EBITDA | 13.17B | 11.22B | 13.21B | 12.38B | 11.86B |
| Net Income | -27.00M | -66.00M | -471.00M | 393.00M | 1.26B |
Balance Sheet | |||||
| Total Assets | 105.41B | 98.76B | 94.56B | 95.06B | 94.22B |
| Cash, Cash Equivalents and Short-Term Investments | 4.06B | 2.58B | 2.71B | 3.13B | 5.04B |
| Total Debt | 68.77B | 53.94B | 54.19B | 51.65B | 49.22B |
| Total Liabilities | 103.86B | 87.24B | 84.86B | 82.30B | 78.74B |
| Stockholders Equity | -1.97B | 7.49B | 2.48B | 11.44B | 14.36B |
Cash Flow | |||||
| Free Cash Flow | 7.75B | 3.08B | 5.32B | 3.43B | 1.78B |
| Operating Cash Flow | 9.81B | 10.63B | 13.35B | 10.34B | 9.70B |
| Investing Cash Flow | -8.15B | -7.70B | -7.46B | -6.01B | -7.62B |
| Financing Cash Flow | -1.37B | -3.26B | -6.27B | -5.83B | -1.57B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$5.55B | 4.65 | 9.36% | 6.79% | 0.52% | 2.07% | |
68 Neutral | HK$577.64B | 13.70 | 7.19% | 5.40% | 0.53% | 5.28% | |
67 Neutral | HK$93.19B | 16.50 | 14.46% | 2.86% | 2.33% | 2.41% | |
65 Neutral | HK$10.14B | 9.94 | 8.45% | 7.46% | -0.62% | -5.10% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
50 Neutral | HK$11.59B | 18.62 | 8.82% | 5.45% | 4.48% | 1820.51% | |
46 Neutral | HK$45.60B | -1,547.01 | -2.39% | 1.68% | 4.26% | 36.68% |